Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.50 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | KCNK3 | O14649 | 3/20 | 0.46 |
| ▸ | KCNK9 | Q9NPC2 | 3/20 | 0.46 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.46 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.46 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.46 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29567244 | 1.00 | GABRA1 (0.50) | GABRA1GABRB2LMNAKCNK3KCNK9 | |
| Hydrogen Peroxide SCHEMBL1652481 | 0.98 | GABRA1 (0.48) | GABRA1GABRB2LMNAKCNK3KCNK9 | |
| SCHEMBL11809743 | 0.86 | KDM4E (0.41) | GABRA1GABRB2LMNAKCNK3KCNK9 | |
| SCHEMBL12903432 | 0.85 | IRAK4 (0.39) | GABRA1GABRB2LMNAKCNK3KCNK9 | |
| SCHEMBL28814411 | 0.85 | IRAK4 (0.43) | LMNATSHRCYP1A2CYP3A4HIF1A | |
| SCHEMBL10726252 | 0.85 | IRAK4 (0.43) | LMNATSHRCYP1A2CYP3A4HIF1A | |
| SCHEMBL12714331 | 0.84 | CES2 (0.41) | LMNACA1CA2KMT2AIRAK4 | |
| SCHEMBL1148330 | 0.83 | GABRA1 (0.52) | GABRA1GABRB2LMNAKCNK3KCNK9 | |
| SCHEMBL9864537 | 0.83 | GABRA1 (0.52) | GABRA1GABRB2LMNAKCNK3KCNK9 | |
| SCHEMBL1344994 | 0.83 | PTGS2 (0.46) | LMNACYP3A4HPGDPTGS1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9174906-B2 | Process for producing optically active secondary alcohol | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2015-11-03 | — | — | US | claimed |
| JP-4672139-B2 | — | — | 2011-04-20 | — | — | JP | claimed |
| EP-1066233-B1 | IMPROVED PROCESS FOR THE PRODUCTION OF A DIHYDROXYBENZENE AND DICARBINOL FROM DIISOPROPYLBENZENE | INDSPEC CHEMICAL CORP (US) | 2003-07-30 | — | — | EP | claimed |
| US-6350921-B1 | CATALYTIC OXIDATION OF DIISOPROPYLBENZENE TO OBTAIN DIHYDROPEROXIDE AND HYDROPEROXIDE, FEEDING AND COUNTERCURRENT EXTRACTION, DECOMPOSITION TO DICARBINOL | INDSPEC CHEMICAL CORPORATION | 2002-02-26 | — | — | US | claimed |
| JP-2002504530-A | — | — | 2002-02-12 | — | — | JP | claimed |
| EP-1066233-A4 | IMPROVED PROCESS FOR THE PRODUCTION OF A DIHYDROXYBENZENE AND DICARBINOL FROM DIISOPROPYLBENZENE | INDSPEC CHEMICAL CORP (US) | 2001-04-25 | — | — | EP | claimed |
| EP-1066233-A1 | IMPROVED PROCESS FOR THE PRODUCTION OF A DIHYDROXYBENZENE AND DICARBINOL FROM DIISOPROPYLBENZENE | INDSPEC CHEMICAL CORPORATION (US) | 2001-01-10 | — | — | EP | claimed |
| WO-1999043637-A1 | IMPROVED PROCESS FOR THE PRODUCTION OF A DIHYDROXYBENZENE AND DICARBINOL FROM DIISOPROPYLBENZENE | INDSPEC CHEMICAL CORPORATION (US) | 1999-09-02 | — | — | WO | claimed |
| US-3950431-A | EXTRACTION WITH A SOLUTION OF AN ALCOHOL AND SODIUM HYDROXIDE OR SODIUM CARBONATE | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-04-13 | — | — | US | claimed |
| US-20240207300-A1 | COMBINATION THERAPIES INCLUDING MYT1 INHIBITORS | SINAI HEALTH SYSTEM (CA) | 2024-06-27 | — | — | US | disclosed |
| US-11873291-B2 | Quinoline cGAS antagonist compounds | IMMUNESENSOR THERAPEUTICS, INC. (US) | 2024-01-16 | — | — | US | disclosed |
| US-20240002374-A1 | 5-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY | GENZYME CORPORATION | 2024-01-04 | — | — | US | disclosed |
| US-20230373935-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS, SAN DIEGO | 2023-11-23 | — | — | US | disclosed |
| US-20230373935-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS, SAN DIEGO | 2023-11-23 | — | — | US | disclosed |
| WO-1999043637-A1 | IMPROVED PROCESS FOR THE PRODUCTION OF A DIHYDROXYBENZENE AND DICARBINOL FROM DIISOPROPYLBENZENE | INDSPEC CHEMICAL CORPORATION (US) | 1999-09-02 | — | — | WO | disclosed |
| EP-0764889-A2 | Toner for developing an electrostatic image | CANON KABUSHIKI KAISHA (JP) | 1997-03-26 | — | — | EP | disclosed |
| EP-0036312-B1 | PROCESS FOR PRODUCING P-NITROANILINE | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1983-09-28 | — | — | EP | disclosed |
| US-4370502-A | NITRATION OF AN ALPHA-METHYLBENZALANILINE USING NITRIC ACID, ANALIPHATIC HALOGEN SOLVENT AND SULFURIC ACID; HYDROLYSIS | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1983-01-25 | — | — | US | disclosed |
| EP-0036312-A2 | Process for producing p-nitroaniline | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1981-09-23 | — | — | EP | disclosed |
| US-3950431-A | EXTRACTION WITH A SOLUTION OF AN ALCOHOL AND SODIUM HYDROXIDE OR SODIUM CARBONATE | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240002374-A1 | 5-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY | CFTR, PKD2, PKD1 | GABRA1 1483/4885GABRB2 1323/4885LMNA 3466/4885 |
| US-11873291-B2 | Quinoline cGAS antagonist compounds | CGAS, GLS2, GLS | GABRA1 1183/4885GABRB2 762/4885LMNA 1681/4885 |
| US-20230373935-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | CFTR, SCNN1G, SCNN1B | GABRA1 910/4885GABRB2 360/4885LMNA 4052/4885 |
| US-20240207300-A1 | COMBINATION THERAPIES INCLUDING MYT1 INHIBITORS | WEE2, WEE1, KAT2A | GABRA1 4685/4885GABRB2 4294/4885LMNA 2157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.